Cited by 29Neonatal Health and BiochemistryBlood groups and transfusionMaternal and Neonatal Healthcare

The DOI matches its Crossref record.

Haemolytic and nonhaemolytic neonatal jaundice have different risk factor profiles

Lee, Brian K., Le Ray, Isabelle, Sun, Ji Yu, Wikman, Agneta, Reilly, Marie, Johansson, Stefan·2016·Acta Paediatrica

Abstract

Aim This study examined maternal and pregnancy risk factors for haemolytic and nonhaemolytic neonatal jaundice in a large population-based cohort study. Methods We conducted a cohort study of 1 019 220 singleton live births from the Swedish medical birth register from 1987 to 2002, using information on neonatal jaundice and maternal and pregnancy characteristics. Diagnoses of gestational hypertensive disorders were obtained by linkage to the national inpatient register. Multivariate logistic regression analysis provided odds ratios for the risk factors of both forms of jaundice. Results A total of 6057 (0.6%) births were affected by haemolytic jaundice and 36 869 (3.6%) by nonhaemolytic jaundice. The strongest risk factors for haemolytic jaundice were maternal alloimmunisation, blood group O and neonatal jaundice in older siblings. For nonhaemolytic jaundice, the strongest risk factors were preterm birth, neonatal jaundice in older siblings, maternal origin from East or South-East Asia and maternal obesity. We estimated that 13% of haemolytic jaundice was attributable to alloimmunisation and 39% of nonhaemolytic jaundice was attributable to preterm birth. Conclusion Haemolytic and nonhaemolytic neonatal jaundice had different risk factor profiles. Interventions to reduce maternal alloimmunisation, preterm birth and maternal obesity may lower the prevalence of neonatal jaundice and the risk of consequent neurological complications.

Overview

Integrity signals

Registry

Crossref · 10.1111/apa.13470

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Research has shown that the prevalence of newborn hyperbilirubinemia may be decreased by interventions that decrease preterm birth.

    “Research has shown that the prevalence of newborn hyperbilirubinemia may be decreased by in­ terventions that decrease preterm birth (Lee et al., 2016).”
  • Preterm birth is the main risk factor for nonhemolytic hyperbilirubinemia.

    “The top risk factor for nonhemolytic hyperbilirubinemia is preterm birth (Lee et al., 2016)”
  • The variance in prevalence could be attributed to the study by Lee et al. only including singleton newborns, whereas this study involved both singleton and multiple pregnancies.

    “The variance in prevalence could be attributed to the fact that the study by Lee et al. only included singleton newborns, whereas this study involved both singleton and multiple pregnancies (Lee et al., 2016).”
  • The total rate of significant neonatal hyperbilirubinemia in this cohort is higher than the reported prevalence of nonhemolytic hyperbilirubinemia of 3.6% between 1987 and 2020 in Sweden.

    “This is higher than the reported prevalence of nonhemolytic hyper­ bilirubinemia of 3.6 % between 1987 and 2020 in Sweden (Lee et al., 2016).”
  • The analysis of neonatal hyperbilirubinemia was constrained by limited access to certain components of participants' medical history, primarily whether the woman had a history of neonatal hyperbilirubinemia.

    “The analysis of neonatal hyper­ bilirubinemia was constrained by limited access to certain components of participants ' medical history, primarily whether the woman had a history of neonatal hyperbilirubinemia, which is a major risk factor (Lee et al., 2016).”

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 20

  1. 10.1136/archdischild-2013-305506 · DOI
  2. 10.1159/000330055 · DOI · Paper page
  3. 10.1111/dmcn.12603 · DOI
  4. 10.1007/s10803-010-1169-6 · DOI
  5. 10.1111/jcpp.12303 · DOI
  6. 10.1016/j.rasd.2014.03.006 · DOI
  7. 10.1371/journal.pone.0027619 · DOI
  8. 10.1111/j.1471-0528.2012.03421.x · DOI
  9. 10.1111/j.1423-0410.2006.00827.x · DOI
  10. 10.1136/bmj.g6572 · DOI
  11. 10.1542/peds.2015-2001 · DOI · Paper page
  12. 10.1002/ajh.23218 · DOI
  13. 10.1192/bjp.bp.111.095125 · DOI · Paper page
  14. 10.1001/jama.2013.6295 · DOI
  15. 10.1097/AOG.0b013e318295657f · DOI
  16. Linn S, 1985, Epidemiology of neonatal hyperbilirubinemia, Pediatrics, 75, 770, 10.1542/peds.75.4.770 · DOI
  17. 10.1159/000293609 · DOI
  18. Strindberg J, 2013, Hemolytic disease of the fetus and newborn owing to anti‐U, successfully treated with repeated intrauterine transfusions, Immunohematology, 29, 51, 10.21307/immunohematology-2019-124 · DOI
  19. 10.1016/j.siny.2008.02.007 · DOI
  20. 10.1001/jama.2009.2014 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Lee, B. K., Le Ray, I., Sun, J. Y., Wikman, A., Reilly, M., & Johansson, S.
Affiliations
  • Karolinska Institutet (SE)
  • Department of Medical Epidemiology and Biostatistics Karolinska Institutet Stockholm Sweden
  • Karolinska University Hospital (SE)
Corresponding author
Johansson, Stefan
Venue
Acta Paediatrica
Publisher
Wiley
Published
2016-06-06
Volume
105
Issue
12
Pages
1444-1450
ISSN
  • 0365-1436 (ISSN-L)
  • 0803-5253
  • 1651-2227
OpenAlex
W2361418622
Cited by
29
References
0
Citations by year
2026: 3 · 2025: 2 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 4 · 2019: 2 · 2018: 3 · 2016: 3
FWCI
3.10
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Paediatrica (publishedVersion)
  • PubMed (publishedVersion)
Funders
Vetenskapsrådet (60521601, C0320601)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
  • Health Sciences › Medicine › Hematology › Blood groups and transfusion
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Maternal and Neonatal Healthcare
Keywords
neonatal jaundice, preterm birth, maternal obesity, hypertensive disorders of pregnancy, blood group O, risk factors, attributable fraction, neurological complications
MeSH terms
Adult, Female, Hemolysis, Humans, Jaundice, Neonatal, Male, Pregnancy, Risk Factors, Sweden, Cohort Studies, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review